[Identification of human testicular embryonal carcinoma proteins by two-dimensional gel electrophoresis and mass spectrometry]. 2009

Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

OBJECTIVE To separate and identify human testicular embryonal carcinoma proteomics using two-dimensional electrophoresis (2-DE) and mass spectrometry. METHODS Immobilized pH gradient two-dimensional polyacrylamide gel electrophoresis was used to separate the total proteins of the samples. After silver staining, PDQuest 7.30 image analysis software was applied to analyze the 2-DE images. Three of the proteins highly expressed in human testicular embryonal carcinoma were identified by matrix-assisted laser adsorption/ionization-time of flight-tandem mass spectrometry (MALDI-TOF-MS/MS). RESULTS 2-DE effectively screened the differentially expressed proteins in the carcinoma tissues. Three proteins highly expressed in the carcinoma were successfully identified. CONCLUSIONS The proteins of human testicular embryonal carcinoma can be effectively separated and analyzed using 2-DE and mass spectrometry. Proteomic analysis offers a new means for further study of this carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013736 Testicular Neoplasms Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms. Cancer of Testis,Cancer of the Testes,Testicular Cancer,Testicular Neoplasm,Testicular Tumor,Testis Cancer,Cancer of the Testis,Neoplasms, Testicular,Neoplasms, Testis,Testicular Tumors,Testis Neoplasms,Tumor of Rete Testis,Cancer, Testicular,Cancer, Testis,Cancers, Testicular,Cancers, Testis,Neoplasm, Testicular,Neoplasm, Testis,Rete Testis Tumor,Rete Testis Tumors,Testicular Cancers,Testis Cancers,Testis Neoplasm,Testis Tumor, Rete,Testis Tumors, Rete,Tumor, Testicular,Tumors, Testicular
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015180 Electrophoresis, Gel, Two-Dimensional Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels. Gel Electrophoresis, Two-Dimensional,Polyacrylamide Gel Electrophoresis, Two-Dimensional,2-D Gel Electrophoresis,2-D Polyacrylamide Gel Electrophoresis,2D Gel Electrophoresis,2D PAGE,2D Polyacrylamide Gel Electrophoresis,Electrophoresis, Gel, 2-D,Electrophoresis, Gel, 2D,Electrophoresis, Gel, Two Dimensional,Polyacrylamide Gel Electrophoresis, 2-D,Polyacrylamide Gel Electrophoresis, 2D,Two Dimensional Gel Electrophoresis,2 D Gel Electrophoresis,2 D Polyacrylamide Gel Electrophoresis,Electrophoresis, 2-D Gel,Electrophoresis, 2D Gel,Electrophoresis, Two-Dimensional Gel,Gel Electrophoresis, 2-D,Gel Electrophoresis, 2D,Gel Electrophoresis, Two Dimensional,PAGE, 2D,Polyacrylamide Gel Electrophoresis, 2 D,Polyacrylamide Gel Electrophoresis, Two Dimensional,Two-Dimensional Gel Electrophoresis
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D018236 Carcinoma, Embryonal A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595) Carcinomas, Embryonal,Embryonal Carcinoma,Embryonal Carcinomas

Related Publications

Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
February 2001, Cellular and molecular life sciences : CMLS,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
January 2005, Journal of proteome research,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
November 2006, Phytochemistry,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
April 2005, Proteomics,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
July 2005, International journal of molecular medicine,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
January 2003, Methods in molecular medicine,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
August 2001, Electrophoresis,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
January 2017, Methods in molecular biology (Clifton, N.J.),
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
January 2000, Methods in enzymology,
Fei Li, and Ya-guang Zou, and Qi-zhao Zhou, and Tie-qiu Li, and Wen-bin Guo, and Xiao-wei Jing, and Xiang-ming Mao, and Wan-long Tan, and Shao-bin Zheng
February 2011, Journal of proteomics,
Copied contents to your clipboard!